Charles Schwab’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $65.4K | Sell |
|
|||||
|
2025
Q1 | $87.6K | Sell |
|
|||||
|
2024
Q4 | $149K | Sell |
|
|||||
|
2024
Q3 | $276K | Buy |
|
|||||
|
2024
Q2 | $488K | Buy |
|
|||||
|
2024
Q1 | $604K | Buy |
|
|||||
|
2023
Q4 | $532K | Buy |
|
|||||
|
2023
Q3 | $380K | Buy |
|
|||||
|
2023
Q2 | $386K | Buy |
|
|||||
|
2023
Q1 | $358K | Sell |
|
|||||
|
2022
Q4 | $385K | Buy |
|
|||||
|
2022
Q3 | $358K | Sell |
|
|||||
|
2022
Q2 | $330K | Sell |
|
|||||
|
2022
Q1 | $524K | Sell |
|
|||||
|
2021
Q4 | $1.06M | Buy |
|
|||||
|
2021
Q3 | $2.63M | Buy |
|
|||||
|
2021
Q2 | $2.08M | Sell |
|
|||||
|
2021
Q1 | $3.24M | Buy |
|
|||||
|
2020
Q4 | $4.91M | Buy |
|